n-acetylneuraminic acid has been researched along with Kidney Diseases in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (27.27) | 18.2507 |
| 2000's | 6 (54.55) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Xiao, G; Xiao, X; Zou, J | 1 |
| Ciccone, C; Darvish, D; Gahl, WA; Hoogstraten-Miller, S; Huizing, M; Kakani, S; Klootwijk, ED; Kopp, JB; Manoli, I; Niethamer, T; Poling, J; Ten Hagen, KG; Tian, E; Yardeni, T; Zerfas, P | 1 |
| Akioka, S; Fukushige, T; Imada, M; Ishiwari, K; Itoh, K; Kanzaki, T; Kobayashi, T; Kotani, M; Pumbo, E; Sakuraba, H; Suzuki, A; Suzuki, M; Tajima, Y; Ueno, T | 1 |
| Carr, G; Sayer, JA; Simmons, NL | 1 |
| Crook, MA; Gopaul, KP | 1 |
| Quaggin, SE | 1 |
| Ciccone, C; Darvish, D; Gahl, WA; Galeano, B; Hoffmann, VJ; Hoogstraten-Miller, S; Huizing, M; Klootwijk, R; Krasnewich, DM; Manoli, I; Starost, MF; Sun, M; Zerfas, PM | 1 |
| Akay, H; Altay, M; Duranay, M; Koşar, U; Oztekin, PS; Parpucu, H; Tekeli, N; Yilmaz, FM; Yilmaz, G; Yücel, D | 1 |
| Gelberg, H; Healy, L; Miller, LA; Vimr, E; Whiteley, H | 1 |
| Azizi, SQ; Dal Nogare, AR; Mason, CM | 1 |
| Bernardini, I; Gahl, WA; Renlund, M; Seppala, R; Tietze, F | 1 |
1 review(s) available for n-acetylneuraminic acid and Kidney Diseases
| Article | Year |
|---|---|
Sialic acid: a novel marker of cardiovascular disease?
Topics: Acute-Phase Reaction; Arteriosclerosis; Biomarkers; Cardiovascular Diseases; Chemistry, Clinical; Diabetes Mellitus; Humans; Kidney Diseases; Leukocytes; Metabolic Syndrome; N-Acetylneuraminic Acid; Risk Factors | 2006 |
10 other study(ies) available for n-acetylneuraminic acid and Kidney Diseases
| Article | Year |
|---|---|
Sialic acid-conjugated PLGA nanoparticles enhance the protective effect of lycopene in chemotherapeutic drug-induced kidney injury.
Topics: Cell Survival; Cells, Cultured; Drug Carriers; Human Umbilical Vein Endothelial Cells; Humans; Hydrogen Peroxide; Kidney Diseases; Lycopene; N-Acetylneuraminic Acid; Nanoparticles; Polylactic Acid-Polyglycolic Acid Copolymer; Protective Agents | 2020 |
The Gne M712T mouse as a model for human glomerulopathy.
Topics: Animals; Biomarkers; Carbohydrate Epimerases; Carrier Proteins; Dietary Supplements; Disease Models, Animal; Drug Evaluation, Preclinical; Hexosamines; Humans; Kidney Diseases; Kidney Glomerulus; Membrane Proteins; Mice; Mice, Mutant Strains; Microscopy, Electron; Mutation; N-Acetylneuraminic Acid; Podocytes; Real-Time Polymerase Chain Reaction; Sialoglycoproteins | 2012 |
Clinical, biochemical, and cytochemical studies on a Japanese Salla disease case associated with a renal disorder.
Topics: Biological Transport; Child, Preschool; Endothelial Cells; Humans; Japan; Kidney Diseases; Kidney Tubules; Lysosomes; Male; N-Acetylneuraminic Acid; Sialic Acid Storage Disease | 2004 |
Disruption of clc-5 leads to a redistribution of annexin A2 and promotes calcium crystal agglomeration in collecting duct epithelial cells.
Topics: Animals; Annexin A2; Calcium; Cell Line; Chloride Channels; Crystallization; Endocytosis; Epithelial Cells; Gene Expression; Kidney Diseases; Kidney Tubules, Collecting; Mice; Mutation; N-Acetylneuraminic Acid; RNA, Messenger; Transfection | 2006 |
Sizing up sialic acid in glomerular disease.
Topics: Animals; Disease Models, Animal; Female; Hexosamines; Humans; Kidney Diseases; Kidney Glomerulus; Mice; Mice, Mutant Strains; Models, Biological; Multienzyme Complexes; N-Acetylneuraminic Acid; Pregnancy | 2007 |
Mutation in the key enzyme of sialic acid biosynthesis causes severe glomerular proteinuria and is rescued by N-acetylmannosamine.
Topics: Animals; Base Sequence; Disease Models, Animal; DNA Primers; Female; Hexosamines; Humans; Kidney Diseases; Kidney Glomerulus; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Mice, Transgenic; Microscopy, Electron; Models, Biological; Multienzyme Complexes; N-Acetylneuraminic Acid; Pregnancy; Proteinuria | 2007 |
Carotid atherosclerosis and cardiovascular risk factors in hemodialysis and peritoneal dialysis patients.
Topics: Adult; C-Reactive Protein; Cardiovascular Diseases; Carotid Artery Diseases; Female; Homocysteine; Humans; Kidney Diseases; Male; Middle Aged; N-Acetylneuraminic Acid; Peritoneal Dialysis; Renal Dialysis; Risk Factors; Thiobarbituric Acid Reactive Substances; Tunica Intima; Ultrasonography | 2007 |
In vivo enzymatic removal of alpha 2-->6-linked sialic acid from the glomerular filtration barrier results in podocyte charge alteration and glomerular injury.
Topics: Albuminuria; Animals; Creatinine; Glomerular Mesangium; Injections, Intraperitoneal; Kidney Diseases; Kidney Glomerulus; Lectins; Male; Mice; Mice, Inbred BALB C; N-Acetylneuraminic Acid; Neuraminidase; Recombinant Proteins; Sialic Acids | 1996 |
Respiratory epithelial carbohydrate levels of rats with gram-negative bacillary colonization.
Topics: Animals; Bacterial Adhesion; Carbohydrate Metabolism; Cheek; Epithelium; Fucose; Gram-Negative Bacteria; Kidney Diseases; Lectins; N-Acetylneuraminic Acid; Oropharynx; Plant Lectins; Rats; Rats, Sprague-Dawley; Ribosome Inactivating Proteins; Sialic Acids; Soybean Proteins; Trachea; Wheat Germ Agglutinins | 1992 |
Renal handling of free sialic acid in normal humans and patients with Salla disease or renal disease.
Topics: Carbohydrate Metabolism, Inborn Errors; Circadian Rhythm; Fanconi Syndrome; Humans; Kidney; Kidney Diseases; N-Acetylneuraminic Acid; Sialic Acids | 1990 |